Neither Ms. Douglass nor Wolfy have access to the innermost memos among the CEOs of drug cos. That fact of the matter is that the drug cos (and most other cos) hedge their outcomes by supporting both sides of this grand debate. Noise.
Johnson & Johnson is the sole supplier to two single-payer systems-China and Russia — at least it was as of a few annual reports ago. J&J supports single payer here because it streamlines things, they don’t have to compete.